Opsonic monoclonal antibodies enhance phagocytic killing activity and clearance of Mycobacterium tuberculosis from blood in a quantitative qPCR mouse model

BACKGROUND: Patients with impaired immunity often have rapid progression of tuberculosis (TB) which can lead to highly lethal Mycobacterium tuberculosis (MTB) sepsis. Opsonic monoclonal antibodies (MABs) directed against MTB that enhance phagocytic killing activity and clearance of MTB from blood ma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Heliyon
Autors principals: Sei, Clara J., Shey, Bong-Akee, Schuman, Richard F., Rikhi, Nimisha, Muema, Kevin, Rodriguez, John D., Daum, Luke T., Fourie, P. Bernard, Fischer, Gerald W.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734336/
https://ncbi.nlm.nih.gov/pubmed/31517107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2019.e02260
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars